Pub. Date : 2019 Jan
PMID : 30111817
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Here we report that NSCLC cells with acquired resistance to gefitinib or osimertinib (AZD9291) exhibit EMT features, with a decrease in E-cadherin, and increases in vimentin and stemness, without possessing any EGFR secondary mutations. | osimertinib | epidermal growth factor receptor | Homo sapiens |